슈뢰딩거(SDGR)는 NASDAQ에 상장된 Healthcare · Health Information Services 기업입니다. 현재가 $29.21 (-3.41%), 시가총액 $0.89B, 52주 최저~최고 $11.07 ~ $26.69.
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multip
슈뢰딩거의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.
슈뢰딩거의 현재 주가는 $29.21 (-3.41%)입니다. BlackAll Trade에서 실시간 시세와 차트를 확인할 수 있습니다.
슈뢰딩거의 시가총액은 약 $0.89B입니다.
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United